Tongee Medical Technology is a biotechnology startup founded in 2016, committed to pioneering advanced medical solutions for metabolic diseases, including obesity, type 2 diabetes, and nonalcoholic fatty liver. The company focuses on developing new medical technologies to treat various metabolic diseases. In its latest investment round in June 2022, Tongee Medical Technology secured a CNY100.00M Series B investment led by Topping Capital and Wuxi Industry Development Group. With a strong emphasis on biotechnology and healthcare, the company is poised to make significant strides in addressing pressing medical challenges.
No recent news or press coverage available for Tongee Medical Technology.